R&D News | pharmaphorum

News

AstraZeneca builds in obesity with $2bn+ Eccogene deal

AstraZeneca headlined its third-quarter earnings update with news of a $185 million upfront licensing deal with Chinese biotech Eccogene for an orally active GLP-1 agonist

News

NHS will pilot blood tests for Alzheimer’s disease

A large-scale study that will pilot the use of blood tests to diagnose Alzheimer’s disease has been announced in the UK, in the hope of finding ways to spot people in the

News

BioNTech flashes the cash, adding tumour drug in $1bn deal

Fresh from slashing its predictions for COVID-19 vaccine sales this year, mRNA specialist BioNTech has used some of its extensive cash reserves to bolster its pipeline in

News

CARGO eyes $300m IPO against lacklustre listings backdrop

CARGO Therapeutics has said it plans to offer around 18.8 million shares in the latest bid by a biotech to list on the Nasdaq, amid a desultory year for initial public off

News

Gilead, Arcus say TIGIT combo encouraging in GI cancer

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy

News

Bayer adds a new life science incubator in China

Bayer’s network of Co.Lab life sciences incubators has expanded once again with the announcement of a new site in Shanghai, China, that will focus on oncology cell and gen

AstraZeneca builds in obesity with $2bn+ Eccogene deal

NHS will pilot blood tests for Alzheimer’s disease

BioNTech flashes the cash, adding tumour drug in $1bn deal

CARGO eyes $300m IPO against lacklustre listings backdrop

Gilead, Arcus say TIGIT combo encouraging in GI cancer

Bayer adds a new life science incubator in China

FDA grants three priority vouchers to psychedelics

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks